title: Development of nerve growth factor (NGF) inhibition as a strategy for treatment of pain.
authors.affiliation: Rinat Laboratories, Pfizer, Inc., South San Francisco, CA, USA.
authors.forename: D
authors.initials: D
authors.lastname: Shelton
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D020932:Nerve Growth Factor / Q000009:adverse effects / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D020932:Nerve Growth Factor; C549319:tanezumab